Hims & Hers Health, Inc. has 11 Schedule 13D or 13G filings on record since 2025-08-13. 4 holders' latest filing reports 5% or more of class a common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 11.9% | 26,496,218 | SCHEDULE 13G/A, 2026-07-28 | 2026-06-30 |
| Andrew Dudum | 9.4% | 22,610,002 | SCHEDULE 13D/A, 2026-08-31 | 2026-08-27 |
| G1 Execution Services, LLC | 6.5% | 14,502,395 | SCHEDULE 13G, 2026-05-15 | 2026-03-31 |
| Vanguard Capital Management | 5.01% | 11,188,807 | SCHEDULE 13G, 2026-07-31 | 2026-06-30 |
| Jpmorgan Chase & Co. | 1.7% | 3,881,790 | SCHEDULE 13G/A, 2026-03-05 | 2026-02-27 |
| Capital World Investors | 0% | 2 | SCHEDULE 13G/A, 2026-05-14 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Purpose of Transaction (Item 4)
Andrew Dudum
The information set forth in Item 4 of the Original Schedule 13D is incorporated herein by reference.Item 4 of the SCHEDULE 13D/A filed 2026-08-31
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | Andrew Dudum | 10.3% | SCHEDULE 13D/A |
| 2025-08-13 | Capital World Investors | 8.6% | SCHEDULE 13G |
| 2025-10-31 | Jpmorgan Chase & Co. | 8.1% | SCHEDULE 13G |
| 2026-02-13 | Capital World Investors | 6.5% | SCHEDULE 13G/A |
| 2026-03-05 | Jpmorgan Chase & Co. | 1.7% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-14 | Capital World Investors | 0% | SCHEDULE 13G/A |
| 2026-05-15 | G1 Execution Services, LLC | 6.5% | SCHEDULE 13G |
| 2026-07-28 | BlackRock, Inc. | 11.9% | SCHEDULE 13G/A |
| 2026-07-31 | Vanguard Capital Management | 5.01% | SCHEDULE 13G |
| 2026-08-31 | Andrew Dudum | 9.4% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Hims & Hers Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.